EUVIMEDOpdag EUVIMED
Übersichtsarbeit

The anomalous pharmacology of fentanyl

Eamonn Kelly iD, Katy Sutcliffe iD, Damiana Cavallo, Nokomis Ramos-Gonzalez, Norah Alhosan, Graeme Henderson iD

British Journal of Pharmacology · 2023-04 · 180 (7) · 797-812

DOI: 10.1111/bph.15573 ↗

At a glance

Übersichtsarbeit in British Journal of Pharmacology, published online on 2021-07-02. Written by Eamonn Kelly and 5 co-authors. Institution: School of Physiology, Pharmacology and Neuroscience, University of Bristol, Bristol, UK. Major MEDLINE topics: Fentanyl, Drug Overdose. Cited 122 times so far (Crossref); 146 references. Funded by: Medical Research Council, Biotechnology and Biological Sciences Research Council (BBSRC), South West Biosciences (SWBio).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Fentanyl is a key therapeutic, used in anaesthesia and pain management. It is also increasingly used illicitly and is responsible for a large and growing number of opioid overdose deaths, especially in North America. A number of factors have been suggested to contribute to fentanyl's lethality, including rapid onset of action, in vivo potency, ligand bias, induction of muscle rigidity and reduced sensitivity to reversal by naloxone. Some of these factors can be considered to represent ‘anomalous’ pharmacological properties of fentanyl when compared with prototypical opioid agonists such as morphine. In this review, we examine the nature of fentanyl's ‘anomalous’ properties, to determine whether there is really a pharmacological basis to support the existence of such properties, and also discuss whether such properties are likely to contribute to overdose deaths involving fentanyls. LINKED ARTICLES This article is part of a themed issue on Advances in Opioid Pharmacology at the Time of the Opioid Epidemic. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v180.7/issuetoc

Subjects

MeSH terms (MEDLINE)

FentanylDrug OverdoseHumansAnalgesics, OpioidNarcotic AntagonistsNaloxone

Author keywords

fentanylopioidreceptor

Substances

FentanylAnalgesics, OpioidNarcotic AntagonistsNaloxone

Authors and institutions

  • School of Physiology, Pharmacology and Neuroscience, University of Bristol, Bristol, UK.

ORCID profiles: Eamonn Kelly, Katy Sutcliffe, Graeme Henderson

Funding

  • Medical Research Council
  • Biotechnology and Biological Sciences Research Council (BBSRC)
  • South West Biosciences (SWBio)
  • Medical Research Council Canada

Cite

APA

Kelly, E., Sutcliffe, K., Cavallo, D., Ramos-Gonzalez, N., Alhosan, N., & Henderson, G. (2023). The anomalous pharmacology of fentanyl. British Journal of Pharmacology, 180(7), 797-812. https://doi.org/10.1111/bph.15573

Vancouver

Kelly E, Sutcliffe K, Cavallo D, Ramos-Gonzalez N, Alhosan N, Henderson G. The anomalous pharmacology of fentanyl. British Journal of Pharmacology. 2023;180(7):797-812. doi:10.1111/bph.15573

BibTeX
@article{Kelly2023,
  author = {Kelly, Eamonn and Sutcliffe, Katy and Cavallo, Damiana and Ramos-Gonzalez, Nokomis and Alhosan, Norah and Henderson, Graeme},
  title = {The anomalous pharmacology of fentanyl},
  journal = {British Journal of Pharmacology},
  year = {2023},
  volume = {180},
  number = {7},
  pages = {797--812},
  doi = {10.1111/bph.15573}
}
Start for free →